Brånvall E, Ekberg S, Eloranta S, et al. - In patients with non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukaemia (CLL), improved lymphoma survival was not achieved with statin use, however, statins seemed safe to use during lymphoma treatment.

• A total 16,098 incident NHL/CLL patients in Sweden from 2007 to 2013 were included.

• Cox regression was applied.

• Statin use at diagnosis was reported by 20% of patients.

• Seemingly, there was no increase in lymphoma-specific mortality in relation to statin use, for actively treated patients with follicular lymphoma.

• In CLL cases, an association of statin use with all-cause and cardiovascular mortality was evident but there was absence of a consistent link with lymphoma-specific mortality.

• Using statins during rituximab treatment seemed a safe treatment strategy.